Nu Genes Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 16-11-2024
- Paid Up Capital ₹ 7.02 M
as on 16-11-2024
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.40 Cr
as on 16-11-2024
- Satisfied Charges ₹ 7.63 Cr
as on 16-11-2024
- Revenue 9.73%
(FY 2023)
- Profit -23.59%
(FY 2023)
- Ebitda -16.02%
(FY 2023)
- Net Worth 29.55%
(FY 2023)
- Total Assets 6.72%
(FY 2023)
About Nu Genes
The Corporate was formerly known as Nitya Seed Sciences Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.02 M.
The company currently has active open charges totaling ₹12.40 Cr. The company has closed loans amounting to ₹7.63 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ganesh Kothawar, Venu Gopal, Raghupathi Kotla, and One other member serve as directors at the Company.
- CIN/LLPIN
U01119TG2004PTC043081
- Company No.
043081
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2004
- Date of AGM
31 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nu Genes Private Limited offer?
Nu Genes Private Limited offers a wide range of products and services, including Food Grains, Bajra, Fresh Vegetables, Bottle Gourd, Raw Maize, Paper Cups, Hot Paper Cup, Bitter Gourd, Natural Flowers, Sunflower.
Who are the key members and board of directors at Nu Genes?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Narayana Punyala | Managing Director | 19-Apr-2004 | Current |
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Venu Gopal | Director | 01-Jul-2020 | Current |
Raghupathi Kotla | Whole-Time Director | 31-Jul-2004 | Current |
Ganesh Kothawar | Director | 01-Jul-2020 | Current |
Financial Performance and Corporate Structure Insights of Nu Genes.
Nu Genes Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.73% increase. The company also saw a substantial fall in profitability, with a 23.59% decrease in profit. The company's net worth Soared by an impressive increase of 29.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Nu Genes?
In 2023, Nu Genes had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Nu Genes International Private LimitedActive 2 years 7 months
Ganesh Kothawar, Raghupathi Kotla and 1 more are mutual person
- Nu Genes Agri Business Private LimitedActive 6 years 1 month
Ganesh Kothawar, Venu Gopal and 2 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 23 Oct 2024 | ₹0.75 M | Open |
Hdfc Bank Limited Creation Date: 11 Mar 2024 | ₹3.20 M | Open |
Hdfc Bank Limited Creation Date: 29 Feb 2024 | ₹0.96 M | Open |
How Many Employees Work at Nu Genes?
Nu Genes has a workforce of 138 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nu Genes, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nu Genes's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.